Why Qudian Shares Jumped Over 40%; Here Are 73 Biggest Movers From Yesterday
Gainers
AMTD Digital Inc. (NYSE: HKD) climbed 71.5% to close at $27.80 on Monday after gaining 108% on Friday. The company priced its IPO at $7 per share.
Recap of Monday’s Biotech Catalysts – End of the Day Summary
Abbvie (NYSE: ABBV) has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least four migraine days per month.
Tesla, Coinbase Global And 41 Stocks Moving In Monday’s Mid-Day Session
Gainers
Intelligent Living Application Group Inc. (NASDAQ: ILAG) shares jumped 90.2% to $4.2792 after declining 11% on Friday. The company reported closing of $20.24 million initial public offering.
Eton Pharmaceuticals Announces FDA Approval Of ZONISADE
Eton Pharmaceuticals, Inc. (NASDAQ:ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has
Dr. Reddy’s Laboratories Announces The Acquisition Of An Injectable Product Portfolio From Eton Pharma For ~$5M In Cash, Up To $45M In Contingent Payments
Dr. Reddy's Laboratories Ltd. ((BSE: 500124, NSE: DRREDDY, NYSE:RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as "Dr. Reddy's")) today announced that it has acquired a
Benzinga Pro’s Top 5 Stocks To Watch For Wednesday, June 1, 2022: TSLA, GME, VTVT, ETON, KYMR
Today's 5 Stock Ideas:
Tesla (TSLA) - ARK Invest's Cathie Wood has purchased about $30 million in Tesla shares over about the last week. Tesla is Cathie's fourth-largest holding, behind Zoom Video
The Week Ahead In Biotech (May 30-June 4): FDA Decision For Eton’s Partnered Epilepsy Drug, ASCO Conference Gets Underway And More
Biotech stocks advanced in the week ended May 27, tracking the overall positive sentiment of the broader market. Notwithstanding the week's strength, the sector has been one of the worst performers for the year-to-date period.
Earnings Outlook For Eton Pharmaceuticals
Eton Pharmaceuticals (NASDAQ:ETON) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement.
Analysts estimate that Eton Pharmaceuticals will report an earnings per share (EPS) of $-0.08.
Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates
The month of April was a mixed one for regulatory approvals. The Food and Drug Administration delayed approvals for at least three treatment candidates. New molecular entity, or NME, approvals, a measure of innovation in drug research, tapered to merely one for the month.